Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today highlighted data presented at the American Association ...
ScienceAlert on MSN
DNA Can Be Built in a Way We've Never Seen Before, Study Finds
A diagram of the DRT3 system, showing Drt3a in yellow and Drt3b in blue. (Hyunbin Lee) Scientists have just discovered an ...
A newly proposed model suggests cancer cells may resist treatment not just through genetic mutations, but by dynamically reprogramming their gene activity. Credit: Shutterstock Cancer cells may “learn ...
A new nanomedicine strategy enhances irinotecan delivery in pancreatic tumors, reduces resistance, and boosts antitumor ...
SEED Therapeutics, Inc. (“SEED”), a clinical-stage biotechnology company pioneering rationally designed molecular glue ...
The idea that cells could be reset emerged from decades of research in regenerative medicine. The field traces back to 1962, ...
A new meeting report was published in Volume 18 of Aging-US on April 6, 2026, titled "Toward actionable interventions in ...
Following Flagship's origination of generative protein and mRNA platforms, Serif is pioneering Modified DNA medicines to program the foundational information layer of biology Serif to present data at ...
Brain organoids reveal that two genetic mutations in DEPDC5 drive epilepsy, disrupting early brain development, and causing ...
Roswell Park researchers present a two-step, mechanism-based drug strategy at AACR 2026 that selectively targets cancers with ...
Storm Therapeutics raises $56M in Series C funding to accelerate cancer therapy development and expand its innovative ...
Chemokines, acting as "traffic controllers" in the tumor microenvironment, regulate immune cell infiltration and local ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results